Related Experiment Videos
Comparative study of assays detecting complement activation. Complement-split product C3d (rocket
G T Espersen1, B Langeland, N Grunnet
1Regional Centre for Blood Transfusion and Clinical Immunology, Aalborg Hospital, Denmark.
Summary
This study compared two complement C3 activation assays, DD-RIE and ELISA, finding good correlation in most patient samples. ELISA showed higher sensitivity for acute complement activation.
Area of Science:
- Immunology
- Clinical Chemistry
- Biochemistry
Background:
- The complement system, particularly C3 activation, plays a crucial role in immune responses and various diseases.
- Accurate measurement of C3 activation products is essential for clinical diagnostics and monitoring disease activity.
- Existing methods for measuring C3d, a key activation product, include double-decker rocket immunoelectrophoresis (DD-RIE) and enzyme-linked immunosorbent assay (ELISA).
Purpose of the Study:
- To investigate the correlation between DD-RIE and ELISA for measuring complement C3d split products.
- To evaluate the clinical applicability of these two assay methods.
- To assess assay performance across different patient populations, including healthy donors, dialysis patients, and rheumatoid arthritis patients.
Main Methods:
- Parallel measurement of 595 blood samples using both DD-RIE and ELISA for C3d estimation.
- Samples included blood donors, patients undergoing dialysis, rheumatoid arthritis patients during steroid treatment, and general patient samples.
- Statistical analysis included calculating mean values, standard deviations, interassay coefficient of variation (CV), and Spearman's rho correlation coefficient.
Main Results:
- Overall, a good correlation (Spearman rho = 0.63) was observed between DD-RIE and ELISA across all 595 samples.
- Mean C3d values were practically identical between the assays for donors, dialysis patients, and general patient samples.
- ELISA demonstrated higher sensitivity in detecting acute complement activation and showed lower C3d levels in rheumatoid arthritis patients with chronic activation compared to DD-RIE.
Conclusions:
- Both DD-RIE and ELISA are reliable methods for measuring complement C3d, showing good correlation in most clinical scenarios.
- ELISA offers advantages in sensitivity for detecting acute complement activation.
- The choice of assay may depend on the specific clinical context, with ELISA potentially being more informative for acute conditions and certain chronic inflammatory states like RA.